PROPOFOL (CIVICA) How Supplied/Storage and Handling

(propofol injectable emulsion)

16 HOW SUPPLIED/STORAGE AND HANDLING

Propofol Injectable Emulsion, USP is supplied as follows:

Unit of SaleConcentration

NDC 72572-590-10
Carton of 10 Single-Patient Use Vials

200 mg/20 mL
(10 mg/mL)

NDC 72572-601-20
Carton of 20 Single-Patient Use Vials

500 mg/50 mL
(10 mg/mL)

NDC 72572-612-10
Carton of 10 Single-Patient Use Vials

1000 mg/100 mL
(10 mg/mL)

Propofol undergoes oxidative degradation, in the presence of oxygen, and is therefore packaged under nitrogen to eliminate this degradation path.

Store between 4°C to 25°C (40°F to 77°F). Do not freeze. Shake well before use. Do not use if there is evidence of excessive creaming or aggregation, if large droplets are visible, or if there are other forms of phase separation indicating that the stability of the product has been compromised. Slight creaming, which should disappear after shaking, may be visible upon prolonged standing.

Find PROPOFOL (CIVICA) medical information:

Find PROPOFOL (CIVICA) medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PROPOFOL (CIVICA) Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

Propofol Injectable Emulsion, USP is supplied as follows:

Unit of SaleConcentration

NDC 72572-590-10
Carton of 10 Single-Patient Use Vials

200 mg/20 mL
(10 mg/mL)

NDC 72572-601-20
Carton of 20 Single-Patient Use Vials

500 mg/50 mL
(10 mg/mL)

NDC 72572-612-10
Carton of 10 Single-Patient Use Vials

1000 mg/100 mL
(10 mg/mL)

Propofol undergoes oxidative degradation, in the presence of oxygen, and is therefore packaged under nitrogen to eliminate this degradation path.

Store between 4°C to 25°C (40°F to 77°F). Do not freeze. Shake well before use. Do not use if there is evidence of excessive creaming or aggregation, if large droplets are visible, or if there are other forms of phase separation indicating that the stability of the product has been compromised. Slight creaming, which should disappear after shaking, may be visible upon prolonged standing.
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.